2 New Hepatitis C Articles at HIVandHepatitis.com

[Guest guest]

4-Drug Regimen Can Cure Genotype 1 Hepatitis C in 12

WeeksInterim results from the Phase 2 ZENITH study show

that previously untreated people with HCV genotype 1 can

achieve sustained response in as little as 12 weeks

using a quadruple regimen consisting of telaprevir

(Incivek), the experimental HCV polymerase inhibitor

VX-222, pegylated interferon, and ribavirin. A newly

added arm will evaluate telaprevir, VX-222, and

ribavirin without interferon.Racial Differences in

Eligibility for Hepatitis C TreatmentBlack hepatitis C

patients were significantly more likely to be deemed

ineligible for treatment, primarily due to neutropenia

and uncontrolled medical conditions, according to a recent

study. Less strict neutrophil eligibility criteria and

more effective care for chronic diseases would increase

access to HCV treatment for black people